E6-AP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of E6-AP Antibodies for investigating cellular processes. E6-AP Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). E6-AP, also known as UBE3A, is an E3 ubiquitin ligase that plays a critical role in protein degradation and regulation of cellular signaling pathways. Research has shown that E6-AP dysfunction can lead to significant cellular abnormalities associated with Angelman syndrome and certain cancers. Understanding E6-AP function is essential for elucidating its role in disease progression and developing potential therapeutic strategies. Researchers can utilize specific monoclonal antibodies to examine E6-AP expression patterns across different cell types and tissues. Advanced imaging techniques combined with E6-AP monoclonal antibodies enable visualization of protein localization and interactions within cellular compartments. Investigating E6-AP's involvement in ubiquitination pathways provides valuable insights into protein degradation mechanisms. Santa Cruz Biotechnology monoclonal antibodies for E6-AP support researchers worldwide in advancing scientific understanding of cellular regulation and disease mechanisms.